Best-Worst Scaling
Showing 1 - 25 of >10,000
What Matters Most to Patients: Establishing Validity
Recruiting
- Hematologic Neoplasms
- Assessment Surveys
- Qualitative Interviews
-
Chapel Hill, North CarolinaLineberger Comprehensive Cancer Center
Apr 11, 2022
Advanced Cancer Trial in San Francisco (Best Case/Worst Case (BC/WC) Geriatric Oncology (GeriOnc) communication tool)
Recruiting
- Cancer
- Best Case/Worst Case (BC/WC) Geriatric Oncology (GeriOnc) communication tool
-
San Francisco, California
- +2 more
Nov 18, 2022
Serious Injury, Communication Trial in United States (Best Case/Worst Case-ICU Communication Tool)
Not yet recruiting
- Serious Injury
- Communication
- Best Case/Worst Case-ICU Communication Tool
-
Birmingham, Alabama
- +7 more
Mar 10, 2023
Palliative Care, Kidney Failure, Chronic, Decision Making Trial in United States (Best Case/Worst Case communication tool
Enrolling by invitation
- Palliative Care
- +13 more
- Best Case/Worst Case communication tool training
-
Denver, Colorado
- +9 more
Jul 21, 2022
Communication Trial in Portland, Dallas (Best Case/Worst Case communication tool)
Completed
- Communication
- Best Case/Worst Case communication tool
-
Portland, Oregon
- +1 more
Dec 23, 2020
Learn More About What Japanese Solid Tumors Think About Taking
Completed
- Cancer Genomic Profiling
- Survey
-
Multiple Locations, JapanMany locations
Oct 12, 2022
Patient Satisfaction and Sensory Attributes Allergic Rhinitis
Completed
- Allergic Rhinitis
- Observational
-
Sydney, New South Wales, AustraliaCommunity and Patient Preference Research Pty Ltd
Jun 29, 2022
Acute Myeloid Leukemia Trial in Rochester (UR-GOAL)
Recruiting
- Acute Myeloid Leukemia
- UR-GOAL
-
Rochester, New YorkUniversity of Rochester
Jun 21, 2022
Telerehabilitation Usability Questionnaire- TrUQ
Not yet recruiting
- Neurological Disease
- Development of the Telerehabilitation Usability Questionnaire
-
Ankara, TurkeyGazi University
Aug 1, 2023
Actinic Keratoses Trial in Worldwide (5-fluorouracil 4% (Tolak), Dexeryl)
Completed
- Actinic Keratoses
- 5-fluorouracil 4% (Tolak)
- Dexeryl
-
Arras, France
- +26 more
Sep 15, 2022
Skin Manifestations Trial in Colorado Springs (metronidazole 1% gel, azelaic acid 15% gel)
Completed
- Skin Manifestations
- metronidazole 1% gel
- azelaic acid 15% gel
-
Colorado Springs, ColoradoThomas J. Stephens & Associates, Inc.
Jul 28, 2022
Skin Manifestations Trial in Carrollton (metronidazole 1% gel, azelaic acid 15% gel)
Completed
- Skin Manifestations
- metronidazole 1% gel
- azelaic acid 15% gel
-
Carrollton, TexasThomas J. Stephens and Associates, Inc.
Jul 28, 2022
Keratosis, Actinic Trial (Tirbanibulin, Vehicle ointment)
Not yet recruiting
- Keratosis, Actinic
- Tirbanibulin
- Vehicle ointment
- (no location specified)
Nov 13, 2023
Netherton Syndrome Trial in Paris (DS-2325a, Placebo)
Not yet recruiting
- Netherton Syndrome
- DS-2325a
- Placebo
-
Paris, FranceSaint Louis Hospital
Jul 31, 2023
Skin Manifestations Trial in Carrollton (adapalene cream 0.1%, adapalene lotion 0.1%)
Completed
- Skin Manifestations
- adapalene cream 0.1%
- adapalene lotion 0.1%
-
Carrollton, TexasThomas J. Stephens & Associates, Inc.
Jul 28, 2022
Pediatric ALL Trial in Worldwide (Methylprednisolone, Prednisolone)
Recruiting
- Paediatric Stroke
-
Randwick, New South Wales, Australia
- +26 more
Jan 13, 2023
Scalp Psoriasis Trial in United States (clobetasol propionate spray 0.05%, Vehicle spray)
Completed
- Scalp Psoriasis
- clobetasol propionate spray 0.05%
- Vehicle spray
-
Los Angeles, California
- +3 more
Jul 28, 2022
Diabetic Foot Ulcer Trial in Hadera (device, diagnostic test, other)
Recruiting
- Diabetic Foot Ulcer
- Study treatment administration (TriO FITT)
- +10 more
-
Hadera, IsraelHilel Yafe Medical Center
Aug 21, 2023
Evaluation of the SCALED (SCaling AcceptabLE cDs)
Not yet recruiting
- Traumatic Brain Injury
- Venous Thromboembolism
- Observational
- Observational-control
- (no location specified)
Nov 16, 2022
Acne Vulgaris Trial in Dallas (Epiduo Gel, Retin-A Micro Microsphere 0.1%)
Completed
- Acne Vulgaris
- Epiduo Gel
- Retin-A Micro Microsphere 0.1%
-
Dallas, TexasStephens and Associates
Jul 28, 2022